Home/Filings/4/0001104659-25-073795
4//SEC Filing

Williamson Susan Ann 4

Accession 0001104659-25-073795

CIK 0001567892other

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 8:52 PM ET

Size

9.1 KB

Accession

0001104659-25-073795

Insider Transaction Report

Form 4
Period: 2025-07-31
Williamson Susan Ann
EVP & Chief Compliance Officer
Transactions
  • Award

    Restricted Stock Units

    2025-07-31+9,7749,774 total
    Ordinary Shares (9,774 underlying)
  • Award

    Ordinary Shares

    2025-07-31+726726 total
Footnotes (3)
  • [F1]On July 31, 2025, pursuant to the Transaction Agreement, dated as of March 13, 2025 (as amended, the "Transaction Agreement"), by and among Mallinckrodt plc (the "Issuer"), Endo, Inc. ("Endo") and Salvare Merger Sub LLC, the Issuer's wholly owned subsidiary ("Merger Sub"), the Merger Sub merged with and into Endo (the "Business Combination"), with Endo surviving the Business Combination as a wholly owned subsidiary of the Issuer. At the Merger Effective Time (as defined in the Transaction Agreement), each share of Endo common stock held by the reporting person immediately prior to the Merger Effective Time automatically converted into the right to receive approximately $1.31 in cash and 0.2575 ordinary shares of the Issuer without interest and subject to applicable withholding.
  • [F2]Effective at the Merger Effective Time, (i) each restricted stock unit in respect of Endo common stock ("Endo RSU") held by the reporting person immediately prior to the Merger Effective Time automatically converted into a restricted unit in respect of a number of ordinary shares of the Issuer ("Issuer RSU") determined in accordance with the formula set forth in the Transaction Agreement and (ii) each performance-based restricted stock unit in respect of Endo common stock ("Endo PSU") held by the reporting person immediately prior to the Merger Effective Time automatically converted into an Issuer RSU in respect of the number of ordinary shares of the Issuer determined in accordance with the formula set forth in the Transaction Agreement assuming the performance goals were achieved based on target performance.
  • [F3]The Issuer RSUs will vest ratably on April 23, 2026 and April 23, 2027. Upon vesting, each Issuer RSU will be settled in ordinary shares of the Issuer at one share per Issuer RSU.

Issuer

Mallinckrodt plc

CIK 0001567892

Entity typeother

Related Parties

1
  • filerCIK 0002076829

Filing Metadata

Form type
4
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 8:52 PM ET
Size
9.1 KB